OBJECTIVE: To investigate whether obesity and hormone therapy (HT) are associated with ovarian cancer risk among women in the California Teachers Study cohort. METHODS: Of 56,091 women age ≥ 45 years, 277 developed epithelial ovarian cancer between 1995 and 2007. Multivariate Cox regression was performed. RESULTS: Among women who never used HT, greater adult weight gain, waist circumference and waist-to-height ratio, but not adult BMI, increased risk of ovarian cancer. Compared to women who never used HT and had a stable adult weight, risk of ovarian cancer was increased in women who gained ≥ 40 lb (relative risk (RR) 1.8, 95% confidence interval (CI): 1.0-3.0) or used HT for >5 years (RR 2.3 95% CI: 1.3-4.1). Having both exposures (RR 1.9, 95% CI: 0.99-3.5), however, did not increase risk more than having either alone. Results were similar for waist circumference and weight-to-height ratio; however, differences across HT groups were not statistically significant. CONCLUSIONS: This study suggests that abdominal adiposity and weight gain, but not overall obesity, increase ovarian cancer risk and that there may be a threshold level beyond which additional hormones, whether exogenous or endogenous, do not result in additional elevation in risk. However, large pooled analyses are needed to confirm these findings.
OBJECTIVE: To investigate whether obesity and hormone therapy (HT) are associated with ovarian cancer risk among women in the California Teachers Study cohort. METHODS: Of 56,091 women age ≥ 45 years, 277 developed epithelial ovarian cancer between 1995 and 2007. Multivariate Cox regression was performed. RESULTS: Among women who never used HT, greater adult weight gain, waist circumference and waist-to-height ratio, but not adult BMI, increased risk of ovarian cancer. Compared to women who never used HT and had a stable adult weight, risk of ovarian cancer was increased in women who gained ≥ 40 lb (relative risk (RR) 1.8, 95% confidence interval (CI): 1.0-3.0) or used HT for >5 years (RR 2.3 95% CI: 1.3-4.1). Having both exposures (RR 1.9, 95% CI: 0.99-3.5), however, did not increase risk more than having either alone. Results were similar for waist circumference and weight-to-height ratio; however, differences across HT groups were not statistically significant. CONCLUSIONS: This study suggests that abdominal adiposity and weight gain, but not overall obesity, increase ovarian cancer risk and that there may be a threshold level beyond which additional hormones, whether exogenous or endogenous, do not result in additional elevation in risk. However, large pooled analyses are needed to confirm these findings.
Authors: Vivien W Chen; Bernardo Ruiz; Jeffrey L Killeen; Timothy R Coté; Xiao Cheng Wu; Catherine N Correa Journal: Cancer Date: 2003-05-15 Impact factor: 6.860
Authors: Penelope M Webb; David M Purdie; Sonia Grover; Susan Jordan; Marie-Louise Dick; Adèle C Green Journal: Gynecol Oncol Date: 2004-01 Impact factor: 5.482
Authors: James V Lacey; Pamela J Mink; Jay H Lubin; Mark E Sherman; Rebecca Troisi; Patricia Hartge; Arthur Schatzkin; Catherine Schairer Journal: JAMA Date: 2002-07-17 Impact factor: 56.272
Authors: Kathleen M Fairfield; Walter C Willett; Bernard A Rosner; JoAnn E Manson; Frank E Speizer; Susan E Hankinson Journal: Obstet Gynecol Date: 2002-08 Impact factor: 7.661
Authors: Jennifer Ose; Helena Schock; Anne Tjønneland; Louise Hansen; Kim Overvad; Laure Dossus; Françoise Clavel-Chapelon; Laura Baglietto; Heiner Boeing; Antonia Trichopolou; Vassiliki Benetou; Pagona Lagiou; Giovanna Masala; Giovanna Tagliabue; Rosario Tumino; Carlotta Sacerdote; Amalia Mattiello; H B As Bueno-de-Mesquita; Petra H M Peeters; N Charlotte Onland-Moret; Elisabete Weiderpass; Inger T Gram; Soledad Sánchez; Mireia Obon-Santacana; Maria-José Sànchez-Pérez; Nerea Larrañaga; José María Huerta Castaño; Eva Ardanaz; Jenny Brändstedt; Eva Lundin; Annika Idahl; Ruth C Travis; Kay-Tee Khaw; Sabina Rinaldi; Isabelle Romieu; Melissa A Merritt; Marc J Gunter; Elio Riboli; Rudolf Kaaks; Renée T Fortner Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-04-08 Impact factor: 4.254
Authors: Melony G King; Sara H Olson; Lisa Paddock; Urmila Chandran; Kitaw Demissie; Shou-En Lu; Niyati Parekh; Lorna Rodriguez-Rodriguez; Elisa V Bandera Journal: BMC Cancer Date: 2013-02-27 Impact factor: 4.430
Authors: Evangelia-Ourania Fourkala; Matthew Burnell; Catherine Cox; Andy Ryan; Laura Currin Salter; Aleksandra Gentry-Maharaj; Mahesh Parmar; Ian Jacobs; Usha Menon Journal: BMJ Open Date: 2014-09-24 Impact factor: 2.692
Authors: Hyo Sook Bae; Jin Hwa Hong; Kyoung-Do Ki; Jae Yun Song; Jin Woo Shin; Jong Min Lee; Jae Kwan Lee; Nak Woo Lee; Chan Lee; Kyu Wan Lee; Yong Min Kim Journal: J Korean Med Sci Date: 2014-05-30 Impact factor: 2.153